Issued Patents All Time
Showing 25 most recent of 53 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11059796 | Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2021-07-13 |
| 10745364 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more | 2020-08-18 |
| 10611740 | Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2020-04-07 |
| 10556898 | Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease | Fernando Padilla, Donald J. Skalitzky, Peter L. Toogood, Chad A. VanHuis | 2020-02-11 |
| 10532088 | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods | Gary D. Glick, Peter L. Toogood, Xiao Hu, Laura L. Celeste, Xikui Liu +2 more | 2020-01-14 |
| 10442798 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2019-10-15 |
| 10421751 | Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2019-09-24 |
| 10392350 | N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | Donald J. Skalitzky, Clarke B. Taylor | 2019-08-27 |
| 10377768 | Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more | 2019-08-13 |
| 10364237 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2019-07-30 |
| 10221146 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more | 2019-03-05 |
| 10208061 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Peter L. Toogood, Xiao Hu | 2019-02-19 |
| 10189777 | Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease | Donald J. Skalitzky, Clarke B. Taylor, Chad A. Van Huis | 2019-01-29 |
| 10112935 | Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease | Fernando Padilla, Peter L. Toogood, Shoujun Chen | 2018-10-30 |
| 10017482 | Mitotic kinesin inhibitors and methods of use thereof | Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Ellen Laird +2 more | 2018-07-10 |
| 9914706 | N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | Donald J. Skalitzky, Clarke B. Taylor | 2018-03-13 |
| 9896441 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Clarke B. Taylor, Chad A. VanHuis | 2018-02-20 |
| 9809561 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more | 2017-11-07 |
| 9802958 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease | Peter L. Toogood, Xiao Hu | 2017-10-31 |
| 9783511 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more | 2017-10-10 |
| 9663502 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more | 2017-05-30 |
| 9657033 | Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more | 2017-05-23 |
| 9512111 | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | Gary D. Glick, Peter L. Toogood, Arthur Glenn Romero, Chad A. Van Huis, Carl Kaub +5 more | 2016-12-06 |
| 9499503 | Mitotic kinesin inhibitors and methods of use thereof | Jeremy Hans, Eli M. Wallace, Qian Zhao, Joseph P. Lyssikatos, Ellen Laird +2 more | 2016-11-22 |
| 9394315 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Peter L. Toogood, Xiao Hu | 2016-07-19 |